SIC
ATYR

Salem Investment Counselors’s aTyr Pharma ATYR Stock Holding History

Salem Investment Counselors’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-40,000
Closed -$84K – 1200
2023
Q1 		$84K Buy
+40,000
New +$87.7K ﹤0.01% 444

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Salem Investment Counselors's ATYR Position: Q2 2023 in Review

Salem Investment Counselors sold out of aTyr Pharma (ATYR) in Q2 2023, closing a stake of 40,000 shares — an estimated $84K sold.

Salem Investment Counselors first reported a position in ATYR in Q1 2023 and held it in 1 quarter. The position peaked at $84K in Q1 2023. 41 funds tracked by Wall St. Rank hold ATYR as of Q2 2023.

  • Salem Investment Counselors reported no remaining aTyr Pharma position as of Q2 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 40,000 aTyr Pharma shares in Q2 2023, an estimated $84K.
  • Salem Investment Counselors first reported a position in aTyr Pharma in Q1 2023 and held it in 1 quarter.
  • Salem Investment Counselors's aTyr Pharma position peaked at $84K in Q1 2023.
  • 41 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2023.

Based on Salem Investment Counselors's 13F filing for Q2 2023, filed 19 Jul 2023.